Allspring Global Investments
LFCR icon

Allspring Global Investments’s Lifecore Biomedical LFCR Stock Holding History

Allspring Global Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Buy
+96,589
New +$487K ﹤0.01% 1451
2024
Q4 		– Sell
-64
Closed -$315 – 2119
2024
Q3 		$315 Buy
+64
New +$334 ﹤0.01% 2391
2023
Q1 		– Sell
-7,115
Closed -$46.1K – 2864
2022
Q4 		$46.1K Sell
7,115
-156
-2% -$1.29K ﹤0.01% 2353
2022
Q3 		$64K Buy
7,271
+5,497
+310% +$55.9K ﹤0.01% 2252
2022
Q2 		$17K Sell
1,774
-29,148
-94% -$289K ﹤0.01% 2519
2022
Q1 		$358K Sell
30,922
-39,461
-56% -$439K ﹤0.01% 2372
2021
Q4 		$781K Buy
+70,383
New +$683K ﹤0.01% 2086

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Allspring Global Investments's LFCR Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 96,589 shares worth $509K. The stake represents ﹤0.01% of the portfolio and ranks #1451 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in LFCR as recently as Q3 2024.

Allspring Global Investments first reported a position in LFCR in Q4 2021 and has held it in 7 quarters since. The position peaked at $781K in Q4 2021. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Allspring Global Investments held 96,589 shares of Lifecore Biomedical worth $509K as of Q2 2026.
  • Lifecore Biomedical was a new Allspring Global Investments position in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1451 holding.
  • Allspring Global Investments first reported a position in Lifecore Biomedical in Q4 2021 and has held it in 7 quarters since.
  • Allspring Global Investments's Lifecore Biomedical position peaked at $781K in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.